Product Information
VASCEPA 1 GM CAPSULE is a brand product labeled by Amarin Pharma Inc., priced at $2.8366 per EA under NDC 52937000120. Its NADAC has been published 567 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the icosapent ethyl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
Amarin Pharma Inc.NDC
52937000120
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
9/18/2024
Active Ingredients
ICOSAPENT ETHYLApproval Type
New Drug (NDA)
FDA Application
NDA202057On Market Since
10/1/2012
Price Statistics
The NADAC for VASCEPA 1 GM CAPSULE has been published 567 times since Nov 28, 2013, and over the history we have for it it has risen 92.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8366 per EA |
|---|---|
| All-time high | $2.8374 (Feb 15, 2023) |
| All-time low | $1.4760 (Nov 28, 2013) |
| Median price | $2.4265 |
| Average price | $2.3293 |
| Largest weekly change | +9.0% (Jan 8, 2020) |
| Weeks tracked | 567 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the icosapent ethyl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VASCEPA 1 GM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VASCEPA 1 GM CAPSULE, manufactured by Amarin Pharma Inc., is $2.8366 per EA (NDC 52937000120), effective Oct 2, 2024.
How has the price of VASCEPA 1 GM CAPSULE changed over time?
Over the history we have for it, the NADAC for VASCEPA 1 GM CAPSULE has risen 92.2%. It has been tracked across 567 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VASCEPA 1 GM CAPSULE?
Since Nov 28, 2013, the NADAC for VASCEPA 1 GM CAPSULE has ranged from a low of $1.4760 (Nov 28, 2013) to a high of $2.8374 (Feb 15, 2023), with a median of $2.4265 per EA.
Are there cheaper alternatives to VASCEPA 1 GM CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VASCEPA 1 GM CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures VASCEPA 1 GM CAPSULE?
VASCEPA 1 GM CAPSULE (NDC 52937000120) is labeled by Amarin Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification